These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18816647)

  • 1. Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?
    Walker D; Orchard T
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S200-1. PubMed ID: 18816647
    [No Abstract]   [Full Text] [Related]  

  • 2. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD?
    Isaacs KL
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S198-9. PubMed ID: 18816779
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extraintestinal complications in patients with ulcerative colitis].
    Oshitani N; Watanabe K; Nakamura S; Higuchi K; Arakawa T
    Nihon Rinsho; 2005 May; 63(5):874-8. PubMed ID: 15881184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel diseases.
    Reinshagen M; von Tirpitz C
    Dig Dis; 2003; 21(2):138-45. PubMed ID: 14571111
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.
    Goldberg I; Finkel O; Gat A; Sprecher E; de Morentin HM
    Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extraintestinal complications of inflammatory bowel disease].
    Kinjo F; Iraha A; Chinen H; Ihama Y; Kishimoto K; Hokama A
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():261-5. PubMed ID: 23126101
    [No Abstract]   [Full Text] [Related]  

  • 10. Important cutaneous manifestations of inflammatory bowel disease.
    Trost LB; McDonnell JK
    Postgrad Med J; 2005 Sep; 81(959):580-5. PubMed ID: 16143688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraintestinal manifestations of Crohn's disease.
    Juillerat P; Mottet C; Froehlich F; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
    Digestion; 2005; 71(1):31-6. PubMed ID: 15711047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.
    Weizman A; Huang B; Berel D; Targan SR; Dubinsky M; Fleshner P; Ippoliti A; Kaur M; Panikkath D; Brant S; Oikonomou I; Duerr R; Rioux J; Silverberg M; Rotter JI; Vasiliauskas E; Haritunians T; Shih D; Li D; Melmed GY; McGovern DP
    Inflamm Bowel Dis; 2014 Mar; 20(3):525-33. PubMed ID: 24487271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraintestinal manifestations of Crohn's disease.
    Juillerat P; Mottet C; Pittet V; Froehlich F; Felley C; Gonvers JJ; Vader JP; Michetti P
    Digestion; 2007; 76(2):141-8. PubMed ID: 18239406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of extraintestinal manifestations of inflammatory bowel disease.
    Grand RJ
    Inflamm Bowel Dis; 1998 Feb; 4(1):72; discussion 73. PubMed ID: 9552233
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD.
    Tremaine WJ
    Inflamm Bowel Dis; 1998 Feb; 4(1):68-9; discussion 73. PubMed ID: 9552230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cutaneous manifestations in inflammatory bowel disease].
    Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts.
    Peyrin-Biroulet L; Loftus EV; Colombel JF; Sandborn WJ
    Inflamm Bowel Dis; 2011 Jan; 17(1):471-8. PubMed ID: 20725943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?
    Satta R; Pes GM; Rocchi C; Pes MC; Dore MP
    J Dermatolog Treat; 2019 Sep; 30(6):612-616. PubMed ID: 30244616
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of the extraintestinal manifestations of inflammatory bowel disease.
    Bernstein CN
    Curr Gastroenterol Rep; 2002 Dec; 4(6):513-6. PubMed ID: 12441042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum?
    Hanauer SB
    Inflamm Bowel Dis; 1998 Feb; 4(1):70; discussion 73. PubMed ID: 9552231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.